Log In
Print this Print this

KI 1001

  Manage Alerts
Collapse Summary General Information
Company Kuhnil Pharmaceutical Co. Ltd.
DescriptionExtended release tablet containing melatonin
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationInsomnia
Indication DetailsTreat insomnia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today